1. Home
  2. QTTB vs GDHG Comparison

QTTB vs GDHG Comparison

Compare QTTB & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$6.20

Market Cap

80.0M

Sector

Health Care

ML Signal

HOLD

Logo Golden Heaven Group Holdings Ltd.

GDHG

Golden Heaven Group Holdings Ltd.

N/A

Current Price

$1.88

Market Cap

32.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
QTTB
GDHG
Founded
2015
2008
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
80.0M
32.9M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
QTTB
GDHG
Price
$6.20
$1.88
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$13.00
N/A
AVG Volume (30 Days)
325.4K
2.5K
Earning Date
05-07-2026
07-11-2025
Dividend Yield
N/A
N/A
EPS Growth
136.78
N/A
EPS
2.42
N/A
Revenue
$53,737,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.40
$0.16
52 Week High
$8.05
$8.69

Technical Indicators

Market Signals
Indicator
QTTB
GDHG
Relative Strength Index (RSI) 53.94 51.79
Support Level $5.51 $1.83
Resistance Level $6.37 $2.23
Average True Range (ATR) 0.76 0.09
MACD -0.12 0.02
Stochastic Oscillator 42.46 74.86

Price Performance

Historical Comparison
QTTB
GDHG

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, it manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants. it opearts in the Cayman Islands, PRC, BVI, and HK.

Share on Social Networks: